Goodwin

Drawing upon deep industry knowledge in core firmwide areas of sector strength, Goodwin is very effective at representing life sciences, tech, real estate and financial services clients in securities litigation and derivative actions in state and federal cases throughout the country. Boston-based Deborah Birnbach has significant expertise handling both private litigation and regulatory investigations, regularly advising companies, as well as their directors and officers, in securities and shareholder litigation and corporate governance matters. In New York, Daniel Roeser has vast experience for an eclectic client base that includes public companies, executives and banks, in the defense of often cutting-edge securities litigation matters, including as it relates to SPACs, cryptocurrency and high frequency trading. Other key members of the team include New York based Douglas Flaum, who regularly handles complex securities litigation in the real estate sector, including for REITs; San Francisco-based Jonathan Shapiro, who is skilled at guiding tech-focused companies (including fintech entities) respond to securities class actions and government investigations and is a key member of the firm’s growing litigation presence in California; and in Boston, Caroline Bullerjahn, who is adept at defending biotech/life sciences companies in securities fraud litigation in courts throughout the country.